Loading data for BNTC — first visit, this takes a few seconds.

アラート

Benitec Biopharma Inc. (BNTC)

NasdaqCM: BNTC · リアルタイム株価 · USD

12.54

+0.20 (1.62%)

終値時点： Aug 19, 2026, 3:59 PM

13.64

+1.94%

時間外: 7:40 PM

1.62% (1D)

買気配	8.9
時価総額	459.66M
売上高（TTM）	n/a
純利益（TTM）	-41.54M
ベータ	0.26
EPS（TTM）	-0.96
PER（TTM）	n/a
予想PER	-1.42
PBR（TTM）	2.51
PSR（TTM）	n/a
Earnings Date	Sep 22, 2026

売気配	16.01
出来高	6,000
平均出来高（20日）	124,382
始値	12.40
前日終値	12.34
当日レンジ	12.40 - 12.77
52週レンジ	9.85 - 16.76
アナリスト	n/a
目標株価	n/a
配当	n/a
権利落ち日	n/a

BNTCについて

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The com...

[続きを読む]

業種 Biotechnology

セクター Healthcare

IPO日 Jun 24, 2014

従業員数 19

上場取引所 NasdaqCM

ティッカー BNTC

ウェブサイト https://benitec.com

企業情報の全文

業績

2025年のBenitec Biopharmaの売上高は0で、前年の0からundefined%の増加でした。利益は-37.92Mで、74.32%の増加でした。

財務諸表

決算サプライズ

Benitec BiopharmaはMay 14, 2026に四半期決算を発表しました：

売上高は $0 で、予想を下回りました $0, うち NaN% の前年比増加にあたります.

EPSは -0.24 で、予想を上回りました 0.04, うち 0.00% の前年比増加にあたります.

次回決算発表

Benitec Biopharma Inc.の決算発表予定日は Sep 22, 2026, 寄り付き前の予定です。
アナリストの売上高予想は ... アップグレード

ニュース

6か月前 · Simply Wall St.

Here's Why We're Not At All Concerned With Benitec Biopharma's (NASDAQ:BNTC) Cash Burn Situation

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

7か月前 · Zacks

Does Benitec Biopharma (BNTC) Have the Potential to Rally 83.87% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 83.9% in Benitec Biopharma (BNTC). While the effectiveness of this highly sought-after metric is questionable, ...

8か月前 · Zacks

Wall Street Analysts Predict an 87.48% Upside in Benitec Biopharma (BNTC): Here's What You Should Know

The mean of analysts' price targets for Benitec Biopharma (BNTC) points to an 87.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement amo...

8か月前 · Zacks

Down 25.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Benitec Biopharma (BNTC)

Benitec Biopharma (BNTC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in ...

9か月前 · Insider Monkey

Citizens Lifts Benitec Biopharma Inc. (BNTC) Price Target on Topline Results for Oculopharyngeal Muscular Dystrophy Treatment

Benitec Biopharma Inc. (NASDAQ:BNTC) is one of the best breakout stocks to invest in. On November 4, an analyst at Citizens JMP raised the stock’s price target to $22 from $20 while reiterating an Out...

2ページ中1ページ

Benitec Biopharma Inc. (BNTC)